Anti-inflammatory therapy for heart failure
- 1 April 2004
- journal article
- review article
- Published by Elsevier in Current Opinion in Pharmacology
- Vol. 4 (2) , 171-176
- https://doi.org/10.1016/j.coph.2003.11.003
Abstract
No abstract availableKeywords
Funding Information
- Ministry of Education, Culture, Sports, Science and Technology
- Ministry of Health, Labour and Welfare
This publication has 41 references indexed in Scilit:
- Randomized, Double-Blind, Placebo-Controlled, Pilot Trial of Infliximab, a Chimeric Monoclonal Antibody to Tumor Necrosis Factor-α, in Patients With Moderate-to-Severe Heart FailureCirculation, 2003
- C-reactive protein in acute myocardial infarction: association with heart failureAmerican Heart Journal, 2003
- Simvastatin Normalizes Autonomic Neural Control in Experimental Heart FailureCirculation, 2003
- Probucol Attenuates Left Ventricular Dysfunction and Remodeling in Tachycardia-Induced Heart FailureCirculation, 2002
- Gene transfer of Fc-fusion cytokine by in vivo electroporation: application to gene therapy for viral myocarditisGene Therapy, 2002
- Effects of Pimobendan on Adverse Cardiac Events and Physical Activities in Patients With Mild to Moderate Chronic Heart FailureCirculation Journal, 2002
- Cytokine Gene Therapy for Myocarditis byIn VivoElectroporationHuman Gene Therapy, 2001
- Pimobendan inhibits the activation of transcription factor NF-κBLife Sciences, 2000
- Increased circulating cytokines in patients with myocarditis and cardiomyopathy.Heart, 1994
- Enhanced expression of superoxide dismutase messenger RNA in viral myocarditis. An SH-dependent reduction of its expression and myocardial injury.Journal of Clinical Investigation, 1993